MedPath

Intraarticular injections for hip osteoarthritis: Steroid versus Hyaluronic acid: randomised controlled trial - Steroid versus hyaluronic acid injections for hip arthritis - Ver 2.2

Phase 1
Conditions
Osteoarthritis of hip joint
MedDRA version: 9.0Level: LLTClassification code 10031161Term: osteoarthritis
Registration Number
EUCTR2009-012442-23-GB
Lead Sponsor
Dorset County Hospital NHS foundation trust
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
110
Inclusion Criteria

Inclusion criteria will be clinical and radiological diagnosis of osteoarthritis (primary or secondary) with failed conservative management but symptoms severity not justifying arthroplasty surgery, Age over 18 years, ability to understand the process and consent.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Exclusion criteria will be presence of any active infection elsewhere, history of previous hip joint infection, pregnancy, patients with a diagnosis of Avascular necrosis of femoral head, rheumatoid arthritis and underlying joint replacement.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: To compare Triamcinolone and hyaluronic acid injections into hip joint for management of early hip osteoarthritis. ;Secondary Objective: None;Primary end point(s): Visual Analaogue scale for pain, Oxford hip score for function.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath